Side Effects of Norifam (Monthly Injectable Contraceptive)
The most common side effects of Norifam (medroxyprogesterone acetate 25 mg + estradiol cypionate 5 mg) are menstrual irregularities—particularly irregular and infrequent bleeding—along with breast tenderness and weight gain, though this monthly injectable causes significantly less bleeding disruption than progestin-only injectables like Depo-Provera 1, 2, 3.
Primary Side Effects
Menstrual Changes (Most Common)
- Irregular bleeding patterns are the leading complaint among users 1
- After 12 months of use, only 44% of women maintain normal menstrual patterns 1
- Irregular and infrequent bleeding are the two most important changes that occur 1
- However, more than two-thirds of women experience predictable, regular cycles—substantially better cycle control than Depo-Provera 2, 3
- Discontinuation due to bleeding problems occurs less than half as often as with progestin-only injectables 3
Other Common Side Effects
Metabolic Effects
Lipid profiles actually improve with Norifam use: total cholesterol, HDL, LDL, VLDL cholesterol, and triglyceride levels all decreased significantly at 12 months in clinical trials 1. This represents a favorable metabolic profile.
Management of Bleeding Irregularities
When patients experience spotting or light bleeding while using injectable contraceptives, the 2024 CDC guidelines recommend 6:
- NSAIDs for 5-7 days as first-line treatment
- Treatment may be repeated as needed
- Provide reassurance that bleeding irregularities are common and typically improve over time
- Always rule out underlying conditions (STIs, pregnancy, thyroid disorders, uterine pathology) if clinically indicated
Cardiovascular Considerations
Research suggests that MPA may counteract some beneficial vascular effects of estradiol in young women, specifically negating estradiol's positive effects on endothelium-dependent vasodilation and endothelin-1 levels 7. However, this formulation has minimal effects on lipids and hemostasis in clinical practice 3.
Return to Fertility
Return to fertility after discontinuation is similar to other hormonal contraceptive methods, with ovulation suppressed for approximately 77 days after the third injection in most women 8.
Critical Clinical Pitfall
Do not confuse this medication with "Norpramin" (desipramine), which is an antidepressant. The FDA drug label evidence provided 9 refers to Norpramin (desipramine), not Norifam contraceptive, and should be disregarded for this question.
Discontinuation Rates
Menstrual disturbances remain the primary reason for discontinuation, though rates are significantly lower than with progestin-only injectables 1, 2. Missed appointments are another common reason for discontinuation, reflecting the challenge of monthly injection schedules 2.